Heart failure is a heterogeneous syndrome. Approximately 30–50% of patients with heart failure have normal or near normal left ventricle function. Several epidemiological studies confirm that the ...

Dr. Hare answers the question: 'Must I Repeat Ejection Fraction Tests?' — -- Question: Should the ejection fraction test be repeated at each visit to my doctor, or at all? Answer: The ejection ...

Heart failure (HF) with preserved ejection fraction (HFpEF) is a complex and increasingly prevalent syndrome, representing nearly half of all HF cases. Characterized by symptoms of HF despite a normal ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...

It is important that all adults with chronic heart failure with reduced ejection fraction are given all appropriate medications at an optimal tolerated dose to best manage their condition and provide ...

Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, ...

Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet RAHWAY, N.J., ...

THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical data was presented at the AHA Annual Scientific ...